ZYBERNO
Stock Report
Updated Aug 26, 2026

ADAPTIN BIO, INC. (APTN)

Healthcare • OTC

$6.27

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
0.0/100
POOR BUSINESS
ADAPTIN BIO, INC. (APTN) scores 0/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-1,299.6%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

ADAPTIN BIO, INC. (APTN) stock report — Zyberno Score 0/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:6.27
Market Cap:$55.48M

Valuation Multiples (1)

Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$54.82M

Price Action & Momentum (1)

% of 52-Week High:100.0%
B. Profitability Assessment

Return Metrics (4)

ROA:-656.7%
Reinvestment Rate:0.0%
Fundamental Growth Rate (g):0.0%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$6.22
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.37x
Quick Ratio:0.37x
Cash Ratio:0.25x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-172.34x
Times Interest Earned:-172.34

Capital Structure (4)

Working Capital:-1,665,350.00
Cash And Cash Equivalents:670,488.00
Long Term Debt:$0.00
Net Debt:-$664.60K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$5.39M

Bottom Line Performance (3)

-$5.40M
Income Before Tax:-$5.40M
Ebitda Ttm:-5,388,399.00

Operating Expenses (5)

Operating Expenses:5,388,399.00
R And D Expense:1,675,443.00
Sga Expense:3,712,956.00
Income Tax Expense:$0.00
Interest Expense:6,639.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$981.45K
Current Assets:$981.45K
Ppe Net:0.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:2,646,802.00
Current Liabilities:2,646,802.00
Long Term Debt:$0.00
Short Term Debt:$5.89K

Equity & Capital (3)

Equity:-$1.67M
Retained Earnings:-$11.64M
Common Stock:50,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:1,674,005.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:345,396.00
C. Cash Flow Analysis

Operating Activities (2)

-$3.09M$0.00

Investment Activities (1)

Investing Cash Flow:$0.00

Financing Activities (3)

Financing Cash Flow:$438.43K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:652,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.65
-$0.39
Earnings Per Share Ttm:-$0.61

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$0.54

Book Value & Capital (2)

Book Value Per Share:-$0.19
Cash Per Share:0.08

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:10.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:0.0%
Fundamental Growth Rate (g):0.0%
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:APTN
Company Name:ADAPTIN BIO, INC.
Sector:Healthcare
Industry:Biological Products, (No Diagnostic Substances)
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:8.85M
Shares Outstanding Basic:8.85M
Shares Outstanding Diluted:8.85M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-26 22:29:41 UTC
Data Timestamp:2026-08-26T22:29:41.405396
Scroll to Top